SEP 1, 2026 · PHASE 2 TRIAL
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
ClinicalTrials.gov
This is a Phase 2 adaptive allocation trial in active recruitment with no results posted; it is designed to identify an efficacious dose and predict Phase 3 success, not to establish clinical benefit.
Reported
Planned enrollment220
Study phasePhase 2
Primary outcome measureDifference in composite CRR-SOFA (cardiovas…